Nobel Minds 2021

TL;DR

Rapid vaccine development demonstrated science’s capacity to respond to a global emergency, but political division and distrust still shape how people accept scientific evidence. Five 2021 Nobel laureates discuss COVID-19, chemistry, research careers, and public confidence, highlighting how fundamental discoveries such as organocatalysis can later support pharmaceutical production and help save lives.

Transcript

hello welcome to nobel mines i'm zain abbadar we here in stockholm home of the nobel prize and this year we're joined by five of our laureates and they're going to be sharing with us some big thoughts and some of the big topics of the day like climate change finding new treatments for covert 19 and migration and its impact on jobs [Applause] [Appla... Read More

Key Insights

• Rapid vaccine development is evidence of science’s ability to address emergencies, according to several laureates. They particularly emphasize the speed of vaccine creation, virus sequencing, and information sharing, while also recognizing that public reactions to these achievements remain divided.
• Public trust in science is affected by political polarization. David Card observes that the United States developed tribal attitudes toward accepting or rejecting vaccines, while Ardem Patapoutian describes continued scientific distrust and anti-vaccine sentiment as deeply worrying.
• Scientific disagreement does not necessarily mean that evidence is evenly divided. Klaus Hasselmann argues that most scientists offer sensible analysis while a small minority attract disproportionate public attention, making scientific conclusions appear less uniform than they actually are.
• Organocatalysis is a method for constructing new and functional molecules using synthetic catalysts. The program describes these catalysts as faster, greener, and easier to control than metal-based catalysts or enzymes, expanding the collection of practical instruments available to chemists.
• Asymmetric chemical construction is important because some processes produce two molecules that are mirror images. One mirror image may have unwanted properties, particularly in pharmaceutical manufacturing, so controlling the direction of molecular construction can be essential when developing drugs.
• Fundamental research can generate applications that were not its immediate objective. Benjamin List says asymmetric organocatalysis began as basic rather than applied research, yet technologies derived from it are already used to manufacture pharmaceuticals and contribute to treatments that save lives.
• Small-molecule drugs can control viral diseases even when vaccines are not responsible for that control. List points to HIV treatment, where patients take several drugs and can live basically healthy lives, including through a pharmaceutical manufactured with technology connected to organocatalysis.
• Scientific careers can begin through curiosity or unexpected exposure. List’s childhood belief that chemists understood what the world was made of drew him toward chemistry, while Patapoutian abandoned a planned medical path after falling in love with discovery and unanswered laboratory questions.

Questions & Answers

Q: How did COVID-19 affect public trust in science?

COVID-19 strengthened confidence in science for many people because vaccines were developed rapidly, the virus was sequenced, and information was shared. However, the pandemic also exposed deep political divisions and persistent distrust. David Card highlights tribal attitudes toward vaccination in the United States, while Ardem Patapoutian warns that anti-vaccine sentiment remains strong despite scientific achievements.

Q: Why do people struggle to decide which scientists to believe?

People may hear a small number of scientists contradict the conclusions presented by the majority, creating an impression that expert opinion is evenly divided. Klaus Hasselmann argues that most scientists provide sensible analysis, while a very small minority produce nonsense and receive public attention because controversy makes discussion more interesting. He recommends learning to recognize and listen to credible scientists.

Q: What is organocatalysis and why is it useful?

Organocatalysis is a method for building molecules with synthetic catalysts. The program presents these catalysts as faster, greener, and easier to control than metal-based catalysts or enzymes. The method expands the chemist’s toolbox and can support the construction of useful substances for pharmaceuticals, solar cells, batteries, lightweight footwear, and materials intended to inhibit disease progression.

Q: How can organocatalysis contribute to pharmaceutical manufacturing?

Technologies developed through asymmetric organocatalysis are already being used to manufacture pharmaceuticals, according to Benjamin List. The approach can help chemists control molecular construction when reactions might otherwise produce mirror-image molecules with different properties. That control is especially important in drug production because one molecular form may have properties that are not wanted in a treatment.

Q: How are small-molecule drugs used against viral diseases?

Small-molecule drugs can treat viral diseases by acting as medicines rather than vaccines. Benjamin List cites HIV as an example, explaining that patients take three or four different drugs and can live basically healthy lives. He also says technology that he helped develop in 2000 is being used to manufacture one of those pharmaceuticals and is saving lives.

Q: Why does Benjamin List describe catalysts as close to magic?

Benjamin List compares catalysis to moving from a magic stick to a single molecule that can transform one material into another. The source of that power is turnover, meaning the catalyst can participate in repeated transformations rather than being consumed in only one event. For List, this repeated molecular activity is what makes catalysts both powerful and beautiful.

Q: What inspired Benjamin List to become a chemist?

Benjamin List became interested in chemistry at age 11, before he had studied the subject at school. He believed chemists knew what the world was made of and understood how molecules behaved, perhaps giving them insight into human behavior and climate change. A library book then taught him experiments, including how to make gunpowder with his brothers.

Q: Why did Ardem Patapoutian choose scientific research over medicine?

Ardem Patapoutian grew up in Lebanon and immigrated to the United States at age 18. He initially followed a pre-medical path because he did not realize that science could be a career. He entered a laboratory mainly to obtain a medical-school recommendation, but became fascinated by discovery, daily research, and the opportunity to ask questions that had not yet been answered.

Summary

This video features Nobel laureates discussing various topics such as the role of science in society, climate change, treatments for COVID-19, migration, and its impact on jobs. The laureates from different fields share their insights and achievements, highlighting the importance of their research in addressing societal issues.

Questions & Answers

Q: How has the COVID-19 pandemic elevated the role of scientists in society?

Benjamin List explains that the pandemic has changed the perception of chemists as people who contribute to environmental pollution. Chemists have been actively involved in developing small molecule drugs to combat COVID-19, which may reshape the view of chemistry in the future.

Q: Has the faith in science and scientists been boosted?

Abdullah Razak Gurner expresses his faith in scientists, especially when it comes to coping with emergencies like the pandemic. The rapid development of vaccines has reinforced his trust in the scientific community.

Q: Do all scientists have the same views and approaches?

Klaus Hasselmann acknowledges that there may be different scientific perspectives, but these differences should not overshadow the fact that the majority of scientists provide valid analyses and solutions. Public perception often focuses on a small percentage of dissenting voices, which can create misunderstandings.

Q: How is Benjamin List's work helping in finding new treatments for COVID-19?

Benjamin List explains that his work in asymmetric organocatalysis is fundamental research that contributes to the development of small molecule drugs used to treat viral diseases like HIV. His research has already been used to make pharmaceuticals and save lives, demonstrating the potential for further advancements in drug development.

Q: What attracted the laureates to their respective fields of research?

Benjamin List was drawn to chemistry at a young age due to the belief that chemists understood everything about the world. Abdullah Razak Gurner's interest in literature developed gradually after immigrating to England, while David Card's passion for economics emerged when he discovered the analytical framework of agricultural markets. Arden Pasha Puccian initially pursued a medical career but found his passion in research upon working in a laboratory.

Q: How have the laureates' personal experiences as immigrants influenced their perspectives?

Abdullah Razak Gurner acknowledges the challenges faced by immigrants, highlighting the risks and difficulties associated with migration. David Card emphasizes the positive economic impacts of immigrants, noting that a significant percentage of Nobel laureates in the sciences are immigrants or children of immigrants.

Q: How difficult is it to get people to change their behavior in response to climate change?

Klaus Hasselmann argues that people often struggle to look beyond short-term perspectives, which hinders the necessary actions to address long-term issues like climate change. Convincing people to change their behavior requires awareness of the long-term consequences and understanding that switching to renewable energy sources can be achieved without major economic impact.

Q: Why is it challenging to promote diversity in science?

Benjamin List acknowledges the lack of diversity, particularly in high academic positions. He believes that diversity should be pursued not only for the sake of justice but also to tap into different pools of talent. Early encouragement of girls and underrepresented groups is crucial in promoting diversity in science.

Q: What research areas could stem from the COVID-19 pandemic as a natural experiment?

David Card notes the potential for research related to the COVID-19 pandemic, such as the transmission of diseases and the improvement of epidemiological models. While challenges exist due to the lack of control groups, the pandemic provides valuable data that can contribute to future understanding and preparedness.

Q: How do the laureates achieve a work-life balance?

David Card confesses that he often prioritizes work over personal life, resulting in some time management challenges and delays for his wife. Klaus Hasselmann finds enjoyment and fulfillment in his work, considering it both work and play. Each laureate likely has their own approach to balancing their personal and professional lives.

Q: Have the laureates experienced significant failures in their scientific careers?

Benjamin List reflects on previous failures but emphasizes the importance of aiming high and not being discouraged by occasional setbacks. David Card highlights uninformative research designs as his failures, acknowledging that failures and challenges are part of the scientific journey.

Q: How does the laureates' research on pain receptors contribute to addressing chronic pain?

Arden Pasha Puccian explains the complexity of pain research, particularly chronic pain. Chronic pain is a major unmet medical need, and their research on touch sensors called piezos shows potential for developing treatments that alleviate chronic pain and associated symptoms.

Q: Has winning the Nobel Prize changed the laureates' perspectives or plans for the future?

Benjamin List shares his excitement and gratitude for being awarded the prize, while expressing a sense of pressure and the need to balance expectations. The laureates generally express their commitment to their work and the continued pursuit of knowledge in their respective fields.

Takeaways

The discussions in this video highlight the essential role of science and scientists in addressing societal challenges. The laureates emphasize the need to trust and appreciate scientific research, particularly during times of crises like the COVID-19 pandemic. They also advocate for diversity in science and encourage the involvement of underrepresented groups. The research achievements showcased in the video demonstrate the potential to improve human lives, whether through the development of drugs, understanding climate change, or addressing chronic pain. Despite the challenges, the laureates remain committed to their work and aspire to make a positive impact on society.

Summary & Key Takeaways

• Five 2021 Nobel laureates join a digital round-table from different locations because COVID-19 travel restrictions prevent an in-person gathering. They consider whether the pandemic strengthened public confidence in science, praising rapid vaccine development and international information sharing while acknowledging political polarization, anti-vaccine sentiment, and confusion caused by dissenting scientific voices.

• Benjamin List describes asymmetric organocatalysis as fundamental research that provides chemists with a method for constructing molecules. Related technologies are already used to manufacture pharmaceuticals, including a drug used against HIV. He emphasizes that catalysts are powerful because a molecule can repeatedly help transform one material into another through chemical turnover.

• The laureates also describe how they entered their fields. List became fascinated with chemistry at age 11 and experimented with gunpowder alongside his brothers. Ardem Patapoutian planned to pursue medicine but discovered a love of unanswered research questions while working in a laboratory. David Card moved toward economics after initially studying physics.